Paratek Pharmaceuticals Inc.

(PRTK) Trade

By |

Profile

Paratek Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on the development and commercialization of therapeutics based upon tetracycline chemistry.

Contact Information

Website: www.paratekpharm.com
Email: info@transcept.com
Main Phone: +1 617 807-6600
Address: 75 Park Plaza
Address 2: 4th Floor
State: MA
City / Town: Boston
Country: USA
Postal Code: 02116

Issuer Information

Exchange: NSD
CEO: Michael Bigham
Employees: 83
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 9.65 $ 0.40 (4.32%)
Last Price 9.65 Change $ 0.40 Change % 4.32 Tick N/A
Bid 9.40 Bid Size 100.00 Ask 10.00 Ask Size 5,000.00
Open 9.20 High 9.70 Low 9.15 Prev Close 9.25
Last Trade Volume 562,490 52 Wk Hi 26.10 52 Wk Low 9.00
Market Cap 306.2 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 31,729,649.00 EPS (TTM) -3.40 PE Ratio N/A Exchange NSD
  Last 3 Mo Last 12 Mo
Number of Insider Trades 10 41
Number of Buys 5 22
Number of Sells 5 19
Net Activity 48418 340385
Last 10 Buys Shares
Richard J. Lim 1,000
Richard J. Lim 1,000
Michael Bigham 1,000
Evan Loh 1,000
Evan Loh 1,000
Evan Loh 1,000
Christopher B. Ehrlich 1,000
Christopher B. Ehrlich 1,000
Glenn A. Oclassen 1,000
Glenn A. Oclassen 1,000
Last 10 Sell Shares
William M. Haskel 1,000
Douglas W. Pagan 1,000
Alan Mendelson 1,000
Evan Loh 1,000
Michael Bigham 1,000
Alan Mendelson 1,000
Robert S. Radie 1,000
Alan Mendelson 1,000
Michael Bigham 1,000
Evan Loh 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 55 55 55 55
Low Target Price Estimate 20 20 20 20
Mean Target Price Estimate 33.22 33.22 35.61 33.22
Standard Deviation 12.23 12.23 12.06 12.23
Date of Most Recent Estimate 05/24/18 05/24/18 05/22/18 05/24/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 8 8 8 8
Moderate Buy 1 1 1 1
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.11 1.11 1.11 1.11